pyrroles has been researched along with ursodeoxycholic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adim, SB; Dolar, E; Gulten, M; Gurel, S; Kiyici, M; Memik, F; Nak, SG; Savci, G; Yerci, O | 1 |
| Georgescu, EF; Georgescu, M | 1 |
| Fauler, G; Gurakuqi, G; März, W; Putz-Bankuti, C; Scharnagl, H; Stadlbauer, V; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M | 1 |
| González-Gallego, J; Mauriz, JL; Tuñón, MJ | 1 |
| Alvaro, D; Attili, AF; Bragazzi, MC; Callea, F; Giubilo, F; Merli, M | 1 |
| Oĭnotkinova, OSh | 1 |
1 review(s) available for pyrroles and ursodeoxycholic acid
| Article | Year |
|---|---|
Apoptotic signaling pathways as a target for the treatment of liver diseases.
Topics: Animals; Apoptosis; Atorvastatin; Gliotoxin; Heptanoic Acids; Humans; Liver Diseases; Molecular Conformation; Pyrroles; Signal Transduction; Ursodeoxycholic Acid | 2008 |
3 trial(s) available for pyrroles and ursodeoxycholic acid
| Article | Year |
|---|---|
Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Fatty Liver; Female; Hepatitis; Heptanoic Acids; Humans; Male; Middle Aged; Prospective Studies; Pyrroles; Ursodeoxycholic Acid | 2003 |
Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
Topics: Adult; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholagogues and Choleretics; Fatty Liver; Female; Hematologic Agents; Hepatitis; Heptanoic Acids; Humans; Losartan; Male; Middle Aged; Pentoxifylline; Pyrroles; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
[Optimization of long-term hypolipidemia treatment of patients with myocardial infarction in combination with non-alcoholic steatohepatitis].
Topics: Atorvastatin; Bilirubin; Fluorobenzenes; Heptanoic Acids; Humans; Hypolipidemic Agents; Lipids; Liver; Middle Aged; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Transaminases; Triglycerides; Ursodeoxycholic Acid | 2014 |
3 other study(ies) available for pyrroles and ursodeoxycholic acid
| Article | Year |
|---|---|
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles; Single-Blind Method; Transaminases; Ursodeoxycholic Acid | 2007 |
Atorvastatin-induced prolonged cholestasis with bile duct damage.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cholestasis; Dyslipidemias; Heptanoic Acids; Humans; Male; Pyrroles; Ursodeoxycholic Acid | 2010 |
[Specific features of hypolipidemic therapy in patients with abdominal ischemic disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Aorta, Abdominal; Atherosclerosis; Atorvastatin; Cholagogues and Choleretics; Drug Therapy, Combination; Fatty Liver; Female; Heptanoic Acids; Humans; Ischemia; Male; Middle Aged; Pyrroles; Ursodeoxycholic Acid; Young Adult | 2012 |